跳至主要内容
临床试验/NCT02146716
NCT02146716已完成不适用

Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2014年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
Cushman Score measure after Energetic Resonance by Cutaneous Stimulation

研究概览

简要总结

The purpose of RESC study is to assess the efficacy of Energetic Resonance by Cutaneous Stimulation on alcohol withdrawal symptoms measured by CUSHMAN score and in a second time to measure the benzodiazepine amount prescribed during the withdrawal time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between 18 and 80 years,
  • Patient with alcohol addiction,
  • Patient needing alcohol withdrawal in a hospital.
  • Patient with social Security,
  • Patient with inform consent signed.

排除标准

  • Pregnant women
  • Major with guardianship.
  • People without sufficient information because of troubles of cognitive functions, or without sufficient knowledge of French language.

研究组 & 干预措施

Control

No Intervention

Energetic Resonance by Cutaneous Stimulation

Experimental

Energetic Resonance by Cutaneous Stimulation session in addition to standard treatment for patients with withdrawal alcohol symptoms.

干预措施: Energetic Resonance by Cutaneous Stimulation (Other)

结局指标

主要结局

Cushman Score measure after Energetic Resonance by Cutaneous Stimulation

时间窗: daily during one week

CUSHMAN score is represented by a scale with 7 variables collecting physiological modifications or behavioural manifestations related to adrenergic answer, neurovegetative signs, confusion, nervousness, perceptive or hallucinatory phenomena.

次要结局

  • Quality of life scale(day 0)
  • Anxiety depression scale(pre-screening, day 3 and day 7)
  • Analogic Visual Scale(before and after each Energetic Resonance by Cutaneous Stimulationsession at day 2, day 4 and day 6.)
  • prescribed benzodiazepine amount(day 0 to day 7)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验